Molina Healthcare, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Molina Healthcare, Inc. on February 16, 2022. The report discloses an amendment to the employment agreement of Joseph M. Zubretsky, the Company's President and Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation adjustments and does not contain financial performance data.
Material Changes
The primary material change reported is the amendment of Mr. Zubretsky's employment agreement, effective February 16, 2022. The amendment modifies the bonus structure as follows:
- Target Bonus: Increased from 150% to 200% of the annual base salary for 2022 and future years.
- Maximum Payout: Set at 400% of the annual base salary then in effect.
- Role: Mr. Zubretsky continues as President and Chief Executive Officer under the same general terms as the existing agreement dated September 8, 2021.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the disclosure of the executive compensation amendment.
Key Facts for Investor Verification
- Verify the specific annual base salary for Mr. Zubretsky to calculate the monetary impact of the increased target bonus (200%) and maximum payout (400%).
- Review the full text of the Amendment of Employment Agreement filed as Exhibit 10.1 for complete terms and conditions.
- Confirm that no other executive departures or appointments occurred concurrently with this amendment.